A comparison between Chek 2 mutation carriers and non carriers in early breast cancer patients: A clinicopathological analysis

被引：0
|
作者：
Huszno, J. [1 ]
Budryk, M. [2 ,3 ]
Tecza, K. [2 ,4 ]
Pilat, J. Pamula [2 ,4 ]
Grzybowska, E. [2 ,4 ]
Kolosza, Z. [2 ,5 ,6 ]
Nowara, E. [1 ]
机构：
[1] Maria Sklodowska Curie Mem Inst Oncol, Clin & Expt Oncol Dept, Gliwice, Poland
[2] MSC Mem Canc Centere, Gliwice, Poland
[3] Inst Oncol, Gliwice Branch, Genet Outpationt Clin, Gliwice, Poland
[4] Inst Oncol, Gliwice Branch, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland
[5] Inst Oncol, Gliwice Branch, Dept Epidemiol, Gliwice, Poland
[6] Silesia Canc Registry, Gliwice, Poland
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30139-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
253
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Breast cancer in Slovene CHEK2 mutation carriers
    Blatnik, A.
    Strojnik, K.
    Stegel, V.
    Drago, V. Etrajcic
    Klancar, G.
    Novakovic, S.
    Krajc, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 412 - 412
  • [2] Correlation between CHEK2 mutation and clinicopathological factors in early breast cancer patients
    Huszno, J.
    Budryk, M.
    Kolosza, Z.
    Nowara, E.
    BREAST, 2015, 24 : S37 - S37
  • [3] Comparison of Nodal Metastasis Between BRCA Mutation Carriers and Non-BRCA Mutation Carriers with Breast Cancer
    Noori, Shahrbanoo F.
    Gangi, Alexandra
    Nelson, Maria E.
    Choi, Michael
    Mirzadehgan, Parisa
    Bonk, Alison K.
    Mirocha, James
    Amersi, Farin
    Giuliano, Armando E.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (10) : 3324 - 3329
  • [4] Comparison of Nodal Metastasis Between BRCA Mutation Carriers and Non-BRCA Mutation Carriers with Breast Cancer
    Shahrbanoo F. Noori
    Alexandra Gangi
    Maria E. Nelson
    Michael Choi
    Parisa Mirzadehgan
    Alison K. Bonk
    James Mirocha
    Farin Amersi
    Armando E. Giuliano
    Annals of Surgical Oncology, 2014, 21 : 3324 - 3329
  • [5] Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers
    Werner Pfeifer
    Anna P. Sokolenko
    Olga N. Potapova
    Alexandr A. Bessonov
    Alexandr O. Ivantsov
    Sergey A. Laptiev
    Olga A. Zaitseva
    Olga S. Yatsuk
    Dmitry E. Matsko
    Tatiana Yu. Semiglazova
    Alexandr V. Togo
    Evgeny N. Imyanitov
    Breast Cancer Research and Treatment, 2014, 148 : 675 - 683
  • [6] Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers
    Pfeifer, Werner
    Sokolenko, Anna P.
    Potapova, Olga N.
    Bessonov, Alexandr A.
    Ivantsov, Alexandr O.
    Laptiev, Sergey A.
    Zaitseva, Olga A.
    Yatsuk, Olga S.
    Matsko, Dmitry E.
    Semiglazova, Tatiana Yu.
    Togo, Alexandr V.
    Imyanitov, Evgeny N.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 675 - 683
  • [7] Clinical and Pathological Features of CHEK2 Mutation Carriers in Breast Cancer
    Lloyd, Christopher
    Rocha, Heather
    Ortiz, Nicole
    Mehr, Chelsea
    LABORATORY INVESTIGATION, 2023, 103 (03) : S174 - S175
  • [8] Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers
    Leedom, Tracey P.
    LaDuca, Holly
    McFarland, Rachel
    Li, Shuwei
    Dolinsky, Jill S.
    Chao, Elizabeth C.
    CANCER GENETICS, 2016, 209 (09) : 403 - 407
  • [9] Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
    Toss, Angela
    Tenedini, Elena
    Piombino, Claudia
    Venturelli, Marta
    Marchi, Isabella
    Gasparini, Elisa
    Barbieri, Elena
    Razzaboni, Elisabetta
    Domati, Federica
    Caggia, Federica
    Grandi, Giovanni
    Combi, Francesca
    Tazzioli, Giovanni
    Dominici, Massimo
    Tagliafico, Enrico
    Cortesi, Laura
    GENES, 2021, 12 (05)
  • [10] Clinicopatological features and outcome of breast cancer in CHEK2 germline mutation carriers
    Schlosser, Shir
    Molho, Rinat Bernstein
    Karminsky, Natalia
    Barsuk, Daphna
    Goldberg, Yael
    Friedman, Eitan
    Yerushalmi, Rinat
    Drumea, Keren
    Kedar, Inbal
    Jiveliouk, Irina
    Ben David, Merav Akiva
    CANCER RESEARCH, 2022, 82 (04)
12345